RUN vs SKYE · P/E 6.0, rev $2.04B vs $25.0M cap
Sunrun Inc (RUN) versus Skye Bioscience, Inc. Common Stock (SKYE) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Skye Bioscience, Inc. Common Stock (SKYE) is a biotechnology company listed on NASDAQ.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
SKYE does not have a complete income-statement cache yet.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. SKYE currently screens at market cap $25.0M.
Not investment advice. Open the RUN and SKYE stock pages for the full models.
Not investment advice.